Emerging Alzheimer's disease treatment paradigms: A late‐stage clinical trial review by Jakub P. Hlávka, Andrew T. Kinoshita, Divya Jeyasingh, Cheng Huang, Leila Mirsafian, Mireille Jacobson

Get full text

Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials by Jeffrey C. Yu, Jakub P. Hlávka, Elizabeth Joe, Frances J. Richmond, Darius N. Lakdawalla

Get full text